SEARCH

SEARCH BY CITATION

References

  • Acosta, J.C., and Gil, J. (2009). A role for CXCR2 in senescence, but what about in cancer? Cancer Res. 69, 21672170.
  • Acosta, J.C., O’Loghlen, A., Banito, A. et al. (2008). Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 10061018.
  • Atkins, M.B. (2006). Cytokine-based therapy and biochemotherapy for advanced melanoma. Clin. Cancer Res. 12, 2353s2358s.
  • Axelrad, T.W., Deo, D.D., Ottino, P., Van Kirk, J., Bazan, N.G., Bazan, H.E., and Hunt, J.D. (2004). Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J. 18, 568570.
  • Balentien, E., Mufson, B.E., Shattuck, R.L., Derynck, R., and Richmond, A. (1991). Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene 6, 11151124.
  • Bedikian, A.Y., Johnson, M.M., Warneke, C.L., McIntyre, S., Papadopoulos, N., Hwu, W.J., Kim, K., and Hwu, P. (2008). Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival. J. Immunotoxicol. 5, 201207.
  • Bedogni, B., Welford, S.M., Cassarino, D.S., Nickoloff, B.J., Giaccia, A.J., and Powell, M.B. (2005). The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 8, 443454.
  • Bedogni, B., Warneke, J.A., Nickoloff, B.J., Giaccia, A.J., and Powell, M.B. (2008). Notch1 is an effector of Akt and hypoxia in melanoma development. J. Clin. Invest. 118, 36603670.
  • Benveniste, J., Henson, P.M., and Cochrane, C.G. (1972). Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J. Exp. Med. 136, 13561377.
  • Benveniste, J., Tence, M., Varenne, P., Bidault, J., Boullet, C., and Polonsky, J. (1979). Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine. C. R. Acad. Sci., D, Sci. Nat. 289, 10371040.
  • Bito, H., Honda, Z., Nakamura, M., and Shimizu, T. (1994). Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur. J. Biochem. 221, 211218.
  • Blank, M.L., Snyder, F., Byers, L.W., Brooks, B., and Muirhead, E.E. (1979). Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem. Biophys. Res. Commun. 90, 11941200.
  • Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., and Kuliopulos, A. (2005). PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303313.
  • Boucharaba, A., Serre, C.M., Gres, S., Saulnier-Blache, J.S., Bordet, J.C., Guglielmi, J., Clezardin, P., and Peyruchaud, O. (2004). Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J. Clin. Invest. 114, 17141725.
  • De Braud, F., Khayat, D., Kroon, B.B., Valdagni, R., Bruzzi, P., and Cascinelli, N. (2003). Malignant melanoma. Crit. Rev. Oncol. Hematol. 47, 3563.
  • Brizzi, M.F., Battaglia, E., Montrucchio, G., Dentelli, P., Del Sorbo, L., Garbarino, G., Pegoraro, L., and Camussi, G. (1999). Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Circ. Res. 84, 785796.
  • Bromberg, M.E., Konigsberg, W.H., Madison, J.F., Pawashe, A., and Garen, A. (1995). Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. U S A 92, 82058209.
  • Bussolati, B., Biancone, L., Cassoni, P., Russo, S., Rola-Pleszczynski, M., Montrucchio, G., and Camussi, G. (2000). PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am. J. Pathol. 157, 17131725.
  • Bussolino, F., Arese, M., Montrucchio, G. et al. (1995). Platelet activating factor produced in vitro by Kaposi’s sarcoma cells induces and sustains in vivo angiogenesis. J. Clin. Invest. 96, 940952.
  • Byrne, S.N., Knox, M.C., and Halliday, G.M. (2008). TGFbeta is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction. Immunol. Cell Biol. 86, 9297.
  • Camussi, G., Montrucchio, G., Lupia, E., De Martino, A., Perona, L., Arese, M., Vercellone, A., Toniolo, A., and Bussolino, F. (1995). Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J. Immunol. 154, 64926501.
  • Camussi, G., Montrucchio, G., Lupia, E., Soldi, R., Comoglio, P.M., and Bussolino, F. (1997). Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J. Immunol. 158, 13021309.
  • Chiang, A.C., and Massague, J. (2008). Molecular basis of metastasis. N. Engl. J. Med. 359, 28142823.
  • Colombo, M.P., Maccalli, C., Mattei, S., Melani, C., Radrizzani, M., and Parmiani, G. (1992). Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines. Melanoma Res. 2, 181189.
  • Countryman, N.B., Pei, Y., Yi, Q., Spandau, D.F., and Travers, J.B. (2000). Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production. J. Invest. Dermatol. 115, 267272.
  • Coussens, L.M., Tinkle, C.L., Hanahan, D., and Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481490.
  • Crowson, A.N., Magro, C., Miller, A., and Mihm, M.C. Jr (2007). The molecular basis of melanomagenesis and the metastatic phenotype. Semin. Oncol. 34, 476490.
  • Cucina, A., Borrelli, V., Di Carlo, A., Pagliei, S., Corvino, V., Santoro-D’Angelo, L., Cavallaro, A., and Sterpetti, A.V. (1999). Thrombin induces production of growth factors from aortic smooth muscle cells. J. Surg. Res. 82, 6166.
  • De Fabo, E.C., Noonan, F.P., Fears, T., and Merlino, G. (2004). Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res. 64, 63726376.
  • De Palma, M., Venneri, M.A., Galli, R., Sergi Sergi, L., Politi, L.S., Sampaolesi, M., and Naldini, L. (2005). Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211226.
  • Demopoulos, C.A., Pinckard, R.N., and Hanahan, D.J. (1979). Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254, 93559358.
  • Denardo, D.G., Johansson, M., and Coussens, L.M. (2008). Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev. 27, 1118.
  • Deo, D.D., Axelrad, T.W., Robert, E.G., Marcheselli, V., Bazan, N.G., and Hunt, J.D. (2002). Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J. Biol. Chem. 277, 2123721245.
  • Deo, D.D., Bazan, N.G., and Hunt, J.D. (2004). Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells. J. Biol. Chem. 279, 34973508.
  • Di Cesare, S., Marshall, J.C., Logan, P., Antecka, E., Faingold, D., Maloney, S.C., and Burnier, M.N. Jr (2007). Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF. J. Carcinog. 6, 2.
  • Duncan, L.M., Richards, L.A., and Mihm, M.C. Jr (1998). Increased mast cell density in invasive melanoma. J. Cutan. Pathol. 25, 1115.
  • Dy, L.C., Pei, Y., and Travers, J.B. (1999). Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor. J. Biol. Chem. 274, 2691726921.
  • Elliott, R.L., and Blobe, G.C. (2005). Role of transforming growth factor Beta in human cancer. J. Clin. Oncol. 23, 20782093.
  • Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., and Bar-Shavit, R. (1998). Thrombin receptor overexpression in malignant and physiological invasion processes. Nat. Med. 4, 909914.
  • Even-Ram, S.C., Maoz, M., Pokroy, E., Reich, R., Katz, B.Z., Gutwein, P., Altevogt, P., and Bar-Shavit, R. (2001). Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin. J. Biol. Chem. 276, 1095210962.
  • Fallani, A., Calorini, L., Mannini, A., Gabellieri, S., Mugnai, G., and Ruggieri, S. (2006). Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line. Prostaglandins Other Lipid Mediat. 81, 171177.
  • Fidler, I.J. (2003). The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat. Rev. Cancer 3, 453458.
  • Fidler, I.J., Kim, S.J., and Langley, R.R. (2007). The role of the organ microenvironment in the biology and therapy of cancer metastasis. J. Cell. Biochem. 101, 927936.
  • Fischer, E.G., Ruf, W., and Mueller, B.M. (1995). Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res. 55, 16291632.
  • Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J.F., Harrington, K., and Sahai, E. (2007). Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 9, 13921400.
  • Gasic, G.J., Gasic, T.B., and Stewart, C.C. (1968). Antimetastatic effects associated with platelet reduction. Proc. Natl. Acad. Sci. U S A 61, 4652.
  • Graves, D.T., Barnhill, R., Galanopoulos, T., and Antoniades, H.N. (1992). Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am. J. Pathol. 140, 914.
  • Haass, N.K., and Herlyn, M. (2005). Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J. Investig. Dermatol. Symp. Proc. 10, 153163.
  • Hansen, K.K., Saifeddine, M., and Hollenberg, M.D. (2004). Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells. Immunology 112, 183190.
  • Haralabopoulos, G.C., Grant, D.S., Kleinman, H.K., and Maragoudakis, M.E. (1997). Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am. J. Physiol. 273, C239C245.
  • Hendrix, M.J., Seftor, E.A., Hess, A.R., and Seftor, R.E. (2003). Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 3, 411421.
  • Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290302.
  • Hsu, M.Y., Meier, F., and Herlyn, M. (2002). Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70, 522536.
  • Huang, Y.Q., Li, J.J., Hu, L., Lee, M., and Karpatkin, S. (2001). Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb. Haemost. 86, 10941098.
  • Im, S.Y., Ko, H.M., Kim, J.W. et al. (1996). Augmentation of tumor metastasis by platelet-activating factor. Cancer Res. 56, 26622665.
  • Ishii, S., Nagase, T., Tashiro, F., Ikuta, K., Sato, S., Waga, I., Kume, K., Miyazaki, J., and Shimizu, T. (1997). Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 16, 133142.
  • Javelaud, D., Alexaki, V.I., and Mauviel, A. (2008). Transforming growth factor-beta in cutaneous melanoma. Pigment Cell Melanoma Res. 21, 123132.
  • Karpatkin, S., and Pearlstein, E. (1981). Role of platelets in tumor cell metastases. Ann. Intern. Med. 95, 636641.
  • Kaushal, V., Kohli, M., Dennis, R.A., Siegel, E.R., Chiles, W.W., and Mukunyadzi, P. (2006). Thrombin receptor expression is upregulated in prostate cancer. Prostate 66, 273282.
  • Kirkwood, J.M., Tarhini, A.A., Panelli, M.C., Moschos, S.J., Zarour, H.M., Butterfield, L.H., and Gogas, H.J. (2008). Next generation of immunotherapy for melanoma. J. Clin. Oncol. 26, 34453455.
  • Ko, H.M., Kang, J.H., Jung, B., Kim, H.A., Park, S.J., Kim, K.J., Kang, Y.R., Lee, H.K., and Im, S.Y. (2007). Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis. Int. J. Cancer 120, 12771283.
  • Koga, M., Kai, H., Egami, K. et al. (2008). Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. Biochem. Biophys. Res. Commun. 365, 279.
  • Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., Van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J., and Peeper, D.S. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 10191031.
  • Kusmartsev, S., Nagaraj, S., and Gabrilovich, D.I. (2005). Tumor-associated CD8 +  T cell tolerance induced by bone marrow-derived immature myeloid cells. J. Immunol. 175, 45834592.
  • Lawson, D.H., Thomas, H.G., Roy, R.G., Gordon, D.S., Chawla, R.K., Nixon, D.W., and Richmond, A. (1987). Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells. J. Cell. Biochem. 34, 169185.
  • Lee, J.T., and Herlyn, M. (2007). Microenvironmental influences in melanoma progression. J. Cell. Biochem. 101, 862872.
  • Li, J.J., Huang, Y.Q., Basch, R., and Karpatkin, S. (2001). Thrombin induces the release of angiopoietin-1 from platelets. Thromb. Haemost. 85, 204206.
  • Li, G., Satyamoorthy, K., Meier, F., Berking, C., Bogenrieder, T., and Herlyn, M. (2003). Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 22, 31623171.
  • Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K., and Flavell, R.A. (2006). Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24, 99146.
  • Liu, Z.J., Xiao, M., Balint, K., Smalley, K.S., Brafford, P., Qiu, R., Pinnix, C.C., Li, X., and Herlyn, M. (2006). Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res. 66, 41824190.
  • Lo, R.S., and Witte, O.N. (2008). Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes. Cancer Res. 68, 42484257.
  • Lopez-Bergami, P., Huang, C., Goydos, J.S. et al. (2007). Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11, 447460.
  • Maliba, R., Lapointe, S., Neagoe, P.E., Brkovic, A., and Sirois, M.G. (2006). Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways. Cell. Signal. 18, 19471957.
  • Mantovani, A. (2005). Cancer: inflammation by remote control. Nature 435, 752753.
  • Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436444.
  • Marathe, G.K., Johnson, C., Billings, S.D., Southall, M.D., Pei, Y., Spandau, D., Murphy, R.C., Zimmerman, G.A., McIntyre, T.M., and Travers, J.B. (2005). Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. J. Biol. Chem. 280, 3544835457.
  • Massi, D., Naldini, A., Ardinghi, C. et al. (2005). Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Hum. Pathol. 36, 676685.
  • Mattei, S., Colombo, M.P., Melani, C., Silvani, A., Parmiani, G., and Herlyn, M. (1994). Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer 56, 853857.
  • Melnikova, V.O., and Bar-Eli, M. (2006). Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res. 19, 395405.
  • Melnikova, V.O., and Bar-Eli, M. (2008). Transcriptional control of the melanoma malignant phenotype. Cancer Biol. Ther. 7, 9971003.
  • Melnikova, V.O., Mourad-Zeidan, A.A., Lev, D.C., and Bar-Eli, M. (2006). Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J. Biol. Chem. 281, 29112922.
  • Michaloglou, C., Vredeveld, L.C., Soengas, M.S., Denoyelle, C., Kuilman, T., Van Der Horst, C.M., Majoor, D.M., Shay, J.W., Mooi, W.J., and Peeper, D.S. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720724.
  • Miller, A.J., and Mihm, M.C. Jr (2006). Melanoma. N. Engl. J. Med. 355, 5165.
  • Mohle, R., Green, D., Moore, M.A., Nachman, R.L., and Rafii, S. (1997). Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. U S A 94, 663668.
  • Montrucchio, G., Lupia, E., Battaglia, E., Passerini, G., Bussolino, F., Emanuelli, G., and Camussi, G. (1994). Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med. 180, 377382.
  • Montrucchio, G., Lupia, E., De Martino, A., Battaglia, E., Arese, M., Tizzani, A., Bussolino, F., and Camussi, G. (1997). Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am. J. Pathol. 151, 557563.
  • Montrucchio, G., Sapino, A., Bussolati, B., Ghisolfi, G., Rizea-Savu, S., Silvestro, L., Lupia, E., and Camussi, G. (1998). Potential angiogenic role of platelet-activating factor in human breast cancer. Am. J. Pathol. 153, 15891596.
  • Moretti, S., Pinzi, C., Spallanzani, A., Berti, E., Chiarugi, A., Mazzoli, S., Fabiani, M., Vallecchi, C., and Herlyn, M. (1999). Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int. J. Cancer 84, 160168.
  • Mrowietz, U., Schwenk, U., Maune, S., Bartels, J., Kupper, M., Fichtner, I., Schroder, J.M., and Schadendorf, D. (1999). The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br. J. Cancer 79, 10251031.
  • Murakami, T., Maki, W., Cardones, A.R., Fang, H., Tun Kyi, A., Nestle, F.O., and Hwang, S.T. (2002). Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62, 73287334.
  • Nakamura, M., Honda, Z., Izumi, T. et al. (1991). Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266, 2040020405.
  • Navarini-Meury, A.A., and Conrad, C. (2008). Melanoma and innate immunity – Active inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines Semin. Cancer Biol. 19, 8491.
  • Nierodzik, M.L., and Karpatkin, S. (2006). Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10, 355362.
  • Nierodzik, M.L., Bain, R.M., Liu, L.X., Shivji, M., Takeshita, K., and Karpatkin, S. (1996). Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Br. J. Haematol. 92, 452457.
  • Nierodzik, M.L., Chen, K., Takeshita, K., Li, J.J., Huang, Y.Q., Feng, X.S., D’Andrea, M.R., Andrade-Gordon, P., and Karpatkin, S. (1998). Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92, 36943700.
  • Noonan, F.P., Recio, J.A., Takayama, H., Duray, P., Anver, M.R., Rush, W.L., De Fabo, E.C., and Merlino, G. (2001). Neonatal sunburn and melanoma in mice. Nature 413, 271272.
  • Norgauer, J., Metzner, B., and Schraufstatter, I. (1996). Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J. Immunol. 156, 11321137.
  • O’Brien, P.J., Molino, M., Kahn, M., and Brass, L.F. (2001). Protease activated receptors: theme and variations. Oncogene 20, 15701581.
  • Owen, J.D., Strieter, R., Burdick, M., Haghnegahdar, H., Nanney, L., Shattuck-Brandt, R., and Richmond, A. (1997). Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int. J. Cancer 73, 94103.
  • Padua, D., and Massague, J. (2009). Roles of TGFbeta in metastasis. Cell Res. 19, 89102.
  • Pei, Y., Barber, L.A., Murphy, R.C., Johnson, C.A., Kelley, S.W., Dy, L.C., Fertel, R.H., Nguyen, T.M., Williams, D.A., and Travers, J.B. (1998). Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J. Immunol. 161, 19541961.
  • Postovit, L.M., Margaryan, N.V., Seftor, E.A., and Hendrix, M.J. (2008). Role of nodal signaling and the microenvironment underlying melanoma plasticity. Pigment Cell Melanoma Res. 21, 348357.
  • Remmel, E., Terracciano, L., Noppen, C., Zajac, P., Heberer, M., Spagnoli, G.C., and Padovan, E. (2001). Modulation of dendritic cell phenotype and mobility by tumor cells in vitro. Hum. Immunol. 62, 3949.
  • Ribatti, D., Ennas, M.G., Vacca, A., Ferreli, F., Nico, B., Orru, S., and Sirigu, P. (2003a). Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur. J. Clin. Invest. 33, 420425.
  • Ribatti, D., Vacca, A., Ria, R., Marzullo, A., Nico, B., Filotico, R., Roncali, L., and Dammacco, F. (2003b). Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer 39, 666674.
  • Richmond, A., Yang, J., and Su, Y. (2009). The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res. 22, 175186.
  • Robert, E.G., and Hunt, J.D. (2001). Lipid messengers as targets for antiangiogenic therapy. Curr. Pharm. Des. 7, 16151626.
  • Robinson, S.C., and Coussens, L.M. (2005). Soluble mediators of inflammation during tumor development. Adv. Cancer Res. 93, 159187.
  • Rollin, S., Lemieux, C., Maliba, R., Favier, J., Villeneuve, L.R., Allen, B.G., Soker, S., Bazan, N.G., Merhi, Y., and Sirois, M.G. (2004). VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis. Blood 103, 37893797.
  • Roth, M., Nauck, M., Yousefi, S., Tamm, M., Blaser, K., Perruchoud, A.P., and Simon, H.U. (1996). Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J. Exp. Med. 184, 191201.
  • Rubtsov, Y.P., and Rudensky, A.Y. (2007). TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 7, 443453.
  • Rudroff, C., Schafberg, H., Nowak, G., Weinel, R., Scheele, J., and Kaufmann, R.. (1998). Characterization of functional thrombin receptors in human pancreatic tumor cells (MIA PACA-2). Pancreas 16, 189194.
  • Ruf, W. (2007). Tissue factor and PAR signaling in tumor progression. Thromb. Res. 120(Suppl 2), S7S12.
  • Ruf, W., and Mueller, B.M. (2006). Thrombin generation and the pathogenesis of cancer. Semin. Thromb. Hemost. 32(Suppl 1), 6168.
  • Rutberg, S.E., Goldstein, I.M., Yang, Y.M., Stackpole, C.W., and Ronai, Z. (1994). Expression and transcriptional activity of AP-1, CRE, and URE binding proteins in B16 mouse melanoma subclones. Mol. Carcinog. 10, 8287.
  • Sato, S., Kume, K., Ito, C., Ishii, S., and Shimizu, T. (1999). Accelerated proliferation of epidermal keratinocytes by the transgenic expression of the platelet-activating factor receptor. Arch. Dermatol. Res. 291, 614621.
  • Schall, T.J., Bacon, K., Toy, K.J., and Goeddel, D.V. (1990). Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347, 669671.
  • Schwarz, T., and Luger, T.A. (1989). Effect of UV irradiation on epidermal cell cytokine production. J. Photochem. Photobiol. B 4, 113.
  • Senger, D.R., Ledbetter, S.R., Claffey, K.P., Papadopoulos-Sergiou, A., Peruzzi, C.A., and Detmar, M. (1996). Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149, 293305.
  • Seo, K.H., Ko, H.M., Choi, J.H., Jung, H.H., Chun, Y.H., Choi, I.W., Lee, H.K., and Im, S.Y. (2004). Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis. Eur. J. Immunol. 34, 21292137.
  • Shimizu, S., Gabazza, E.C., Hayashi, T., Ido, M., Adachi, Y., and Suzuki, K. (2000). Thrombin stimulates the expression of PDGF in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L503L510.
  • Sirois, M.G., and Edelman, E.R. (1997). VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am. J. Physiol. 272, H2746H2756.
  • Tellez, C., and Bar-Eli, M. (2003). Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 22, 31303137.
  • Tellez, C., McCarty, M., Ruiz, M., and Bar-Eli, M. (2003). Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J. Biol. Chem. 278, 4663246642.
  • Tellez, C.S., Davis, D.W., Prieto, V.G., Gershenwald, J.E., Johnson, M.M., McCarty, M.F., and Bar-Eli, M. (2007). Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression. J. Invest. Dermatol. 127, 387393.
  • Timar, J., Tovari, J., Raso, E., Meszaros, L., Bereczky, B., and Lapis, K. (2005). Platelet-mimicry of cancer cells: epiphenomenon with clinical significance. Oncology 69, 185201.
  • Tlsty, T.D., and Coussens, L.M. (2006). Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1, 119150.
  • Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S., and Kuwano, M. (2000). Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int. J. Cancer 85, 182188.
  • Ueno, A., Murakami, K., Yamanouchi, K., Watanabe, M., and Kondo, T. (1996). Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells. Immunology 88, 7681.
  • Ullrich, S.E. (2005). Mechanisms underlying UV-induced immune suppression. Mutat. Res. 571, 185205.
  • Villanueva, J., and Herlyn, M. (2008). Melanoma and the tumor microenvironment. Curr. Oncol. Rep. 10, 439446.
  • Villares, G.J., Zigler, M., Wang, H. et al. (2008). Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Res. 68, 90789086.
  • Walterscheid, J.P., Ullrich, S.E., and Nghiem, D.X. (2002). Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. 195, 171179.
  • Weber, J.S. (2008). Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanoma. J. Invest. Dermatol. 128, 27502752.
  • Witz, I.P. (2008). Tumor-microenvironment interactions: dangerous liaisons. Adv. Cancer Res. 100, 203229.
  • Wojtukiewicz, M.Z., Tang, D.G., Nelson, K.K., Walz, D.A., Diglio, C.A., and Honn, K.V. (1992). Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface. Thromb. Res. 68, 233245.
  • Wojtukiewicz, M.Z., Tang, D.G., Ben-Josef, E., Renaud, C., Walz, D.A., and Honn, K.V. (1995). Solid tumor cells express functional “tethered ligand” thrombin receptor. Cancer Res. 55, 698704.
  • Yang, J., Luan, J., Yu, Y., Li, C., DePinho, R.A., Chin, L., and Richmond, A. (2001). Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res. 61, 81508157.
  • Ye, R.D., Prossnitz, E.R., Zou, A.H., and Cochrane, C.G. (1991). Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem. Biophys. Res. Commun. 180, 105111.
  • Zhang, C., Zhang, F., Tsan, R., and Fidler, I.J. (2009). Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res. 69, 828835.
  • Zucker, S., Conner, C., DiMassmo, B.I., Ende, H., Drews, M., Seiki, M., and Bahou, W.F. (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J. Biol. Chem. 270, 2373023738.